DGRA e.V. DGRA e.V.

  • Home
  • DGRA
    • Aktuelles
    • Vorstellung
    • Geschäftsstelle
    • Vorstand
    • Mitgliederentwicklung
    • Förderung
        Walter-Cyran-Medaille DGRA-Förderpreis DGRA-Studienpreis Promotionsstipendium
    • Informationsmaterial
    • Satzung
    • Historie
  • Mitgliedschaft
    • Antrag Mitgliedschaft Firmenmitglied
    • Antrag Mitgliedschaft Privatperson
  • Fortbildungen
    • Jahreskongresse
    • Workshops
    • Lunch & Learn
    • Schools
    • AGB
  • Degree programme
    • News
    • Offered courses
        Master's degree programme Certificate course Single modules Application Student advisory service Examination board
    • In your studies
        Study plan (MDRA-27) Study modules (MDRA-27) Study modules (MDRA-26) Internship Master's thesis Lecturer Literature
    • Testimonials
    • Career perspectives
    • Press and media
    • FAQ
    • Downloads from A-Z
  • Karriere
    • Stellenangebote
    • Praktikumsangebote
  • Kontakt
  • English
    • DGRA
        Business Office Board of Directors Articles of Association
    • Awards and Scholarship
        Walter Cyran Award DGRA Award DGRA Study Award DGRA Doctoral Scholarship Lorenz Scholarship
    • Membership
        Application membership companies Application membership private individuals
    • Information Material
    • Contact
  • Home
  • DGRA
    • Aktuelles
    • Vorstellung
    • Geschäftsstelle
    • Vorstand
    • Mitgliederentwicklung
    • Förderung
        Walter-Cyran-Medaille DGRA-Förderpreis DGRA-Studienpreis Promotionsstipendium
    • Informationsmaterial
    • Satzung
    • Historie
  • Mitgliedschaft
    • Antrag Mitgliedschaft Firmenmitglied
    • Antrag Mitgliedschaft Privatperson
  • Fortbildungen
    • Jahreskongresse
    • Workshops
    • Lunch & Learn
    • Schools
    • AGB
  • Degree programme
    • News
    • Offered courses
        Master's degree programme Certificate course Single modules Application Student advisory service Examination board
    • In your studies
        Study plan (MDRA-27) Study modules (MDRA-27) Study modules (MDRA-26) Internship Master's thesis Lecturer Literature
    • Testimonials
    • Career perspectives
    • Press and media
    • FAQ
    • Downloads from A-Z
  • Karriere
    • Stellenangebote
    • Praktikumsangebote
  • Kontakt
  • English
    • DGRA
        Business Office Board of Directors Articles of Association
    • Awards and Scholarship
        Walter Cyran Award DGRA Award DGRA Study Award DGRA Doctoral Scholarship Lorenz Scholarship
    • Membership
        Application membership companies Application membership private individuals
    • Information Material
    • Contact
DE EN Anmelden

Masterarbeit

Implementing CMC Section of the Clinical Trial Directive

Hiu Wah Yuen (2005)

Language: English

The Directive 2001/20/EC dated April 4th, 2001 was published on 1st May 2001 in Official Journal of European Communities.

Implementation date should be till 1st May 2004. This has had a big impact on the Member States, and 2004 was a year of changes. Due to implementation, the requirements of each Member State changed nearly daily. But now, almost all countries have implemented the directive.

The principal aim is certainly the harmonisation of conducting clinical trials within EU. A lot of effort has and is being made to ensure same and high standards regarding safety and quality in clinical trials. The procedures should be clear and transparent throughout the EU.
But do we have already a harmonisation throughout the EU?

In my opinion, a global or even a European harmonisation has still not yet been reached. But, nevertheless, due to the clinical trial directive a big step has been taken. The main focus of my study of literature is how to include quality data into the IMPD. Especially, quality data in the early phases should be a satisfactory progress to public safety. This should guarantee the quality of the product in the very early phase of development. Thus, implementing the quality part was and is recently a big issue.

All pharmaceutical companies, which are involved in clinical trials, are going forward to improve the strategy of CTA submission as well as their clinical research based on high standards.
The competent authorities have to review much more documentation and they also require more resources to do so in less time with more pressure.

Furthermore, the ethics committees have to get used to their new role, which means the evaluation of documentation also in fixed timelines, but this work is regulated by law.
Finally, it should be pointed out, that the clinical trial directive has changed conducting clinical trials in Man, however an increasing of complexity and cost for clinical trials cannot be avoided.
 
Pages: 50

Zurück zur Übersicht
Newsletter

Melden Sie sich jetzt für unseren

Newsletter an.

Abonnieren!

DGRA e.V.

Adenauerallee 15

D-53111 Bonn

Telefon: 0228 / 368 26 46

Fax: 0228 / 368 26 47

E-Mail: info@dgra.de

Kooperationspartner

Uni Bonn

© 2025 Deutsche Gesellschaft für Regulatory Affairs e.V.

LinkedIn Datenschutz Impressum